EP3512529A4 - Compositions et procédés d'administration de médicament - Google Patents
Compositions et procédés d'administration de médicament Download PDFInfo
- Publication number
- EP3512529A4 EP3512529A4 EP16916372.2A EP16916372A EP3512529A4 EP 3512529 A4 EP3512529 A4 EP 3512529A4 EP 16916372 A EP16916372 A EP 16916372A EP 3512529 A4 EP3512529 A4 EP 3512529A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- drug delivery
- delivery compositions
- compositions
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2016/052240 WO2018052443A1 (fr) | 2016-09-16 | 2016-09-16 | Compositions et procédés d'administration de médicament |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3512529A1 EP3512529A1 (fr) | 2019-07-24 |
EP3512529A4 true EP3512529A4 (fr) | 2020-05-06 |
Family
ID=61619222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16916372.2A Withdrawn EP3512529A4 (fr) | 2016-09-16 | 2016-09-16 | Compositions et procédés d'administration de médicament |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3512529A4 (fr) |
WO (1) | WO2018052443A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10980922B2 (en) * | 2016-05-03 | 2021-04-20 | Medtronic, Inc. | Hemostatic devices and methods of use |
US10933174B2 (en) | 2016-05-03 | 2021-03-02 | Medtronic, Inc. | Hemostatic devices and methods of use |
US10765782B2 (en) | 2016-05-03 | 2020-09-08 | Medtronic, Inc. | Hemostatic devices and methods of use |
EP4294183A1 (fr) | 2021-02-17 | 2023-12-27 | Oxion Dental, LLC | Compositions antiseptiques actives stabilisées générant de l'oxygène, solutions d'irrigation, et articles |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4725576A (en) * | 1983-12-29 | 1988-02-16 | Research Foundation Of State University Of New York | Fungicidal polypeptide compositions containing L-histidine and methods for use therefore |
US20110044914A1 (en) * | 2008-02-08 | 2011-02-24 | Colgate -Palmolive Company | Cleaning compositions and methods |
US20110212187A1 (en) * | 2008-09-17 | 2011-09-01 | Taminco | Antimicrobial composition |
US20110229583A1 (en) * | 2010-03-17 | 2011-09-22 | David Van Tran | Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6361551B1 (en) * | 1998-12-11 | 2002-03-26 | C. R. Bard, Inc. | Collagen hemostatic fibers |
US20120074014A1 (en) * | 2010-09-27 | 2012-03-29 | Lutran Industries, Inc. | Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication |
-
2016
- 2016-09-16 WO PCT/US2016/052240 patent/WO2018052443A1/fr unknown
- 2016-09-16 EP EP16916372.2A patent/EP3512529A4/fr not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4725576A (en) * | 1983-12-29 | 1988-02-16 | Research Foundation Of State University Of New York | Fungicidal polypeptide compositions containing L-histidine and methods for use therefore |
US20110044914A1 (en) * | 2008-02-08 | 2011-02-24 | Colgate -Palmolive Company | Cleaning compositions and methods |
US20110212187A1 (en) * | 2008-09-17 | 2011-09-01 | Taminco | Antimicrobial composition |
US20110229583A1 (en) * | 2010-03-17 | 2011-09-22 | David Van Tran | Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid |
Non-Patent Citations (1)
Title |
---|
See also references of WO2018052443A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP3512529A1 (fr) | 2019-07-24 |
WO2018052443A1 (fr) | 2018-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3355954A4 (fr) | Méthodes et compositions d'administration | |
EP3558424A4 (fr) | Systèmes et procédés d'administration de médicaments | |
EP3294398A4 (fr) | Systèmes et procédés d'administration de médicaments | |
EP3300507A4 (fr) | Méthodes et compositions d'administration génique | |
EP3411414A4 (fr) | Compositions et méthodes pour l'administration ciblée de cytokines | |
EP3250258A4 (fr) | Procédés et systèmes d'administration de médicament | |
EP3426348A4 (fr) | Dérivé de 3-désoxy et compositions pharmaceutiques associées | |
EP3265064A4 (fr) | Dispositif d'administration de médicament | |
EP3357513A4 (fr) | Composition pharmaceutique et application de cette dernière | |
EP3094343A4 (fr) | Formulations d'insuline à action rapide et systèmes d'administration pharmaceutique | |
EP3310343A4 (fr) | Compositions implantables pour administration de médicaments et méthodes d'utilisation desdites compositions | |
EP3474857A4 (fr) | Compositions et méthodes de libération d'agents thérapeutiques | |
EP3434285A4 (fr) | Composition pharmaceutique et ses utilisations | |
EP3233192A4 (fr) | Compositions et méthodes pour l'administration ciblée de médicaments | |
EP3307265A4 (fr) | Association pharmaceutique et utilisations de cette association | |
EP3378482A4 (fr) | Formulation pour l'administration d'antimoraux | |
EP3177286A4 (fr) | Compositions et méthodes d'administration physiologique à l'aide de cannabidiol | |
EP3182970A4 (fr) | Compositions et procédés d'enrobages en cannabinoïdes utilisés dans l'administration de médicaments | |
EP3723750A4 (fr) | Médicaments et compositions à administrer par voie oculaire | |
ZA202001044B (en) | Drug delivery composition | |
EP3091983A4 (fr) | Produits et compositions pharmaceutiques | |
EP3560518A4 (fr) | Complexe pour l'administration et la stabilisation d'un médicament et son procédé de préparation | |
EP3185873A4 (fr) | Composition pharmaceutique et procédés | |
EP3388085A4 (fr) | Composition pharmaceutique et ses utilisations | |
EP3512529A4 (fr) | Compositions et procédés d'administration de médicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20190404 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200402 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 33/04 20060101ALI20200328BHEP Ipc: A61K 33/40 20060101AFI20200328BHEP Ipc: A61L 15/46 20060101ALI20200328BHEP Ipc: A61L 15/18 20060101ALI20200328BHEP Ipc: A61P 17/02 20060101ALI20200328BHEP Ipc: A61L 15/26 20060101ALI20200328BHEP Ipc: A61L 15/32 20060101ALI20200328BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20200819 |